Clinical Trial Update: Insulin Glulisine in Healthy Lean and Obese Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating insulin glulisine in healthy lean and obese subjects with diabetes mellitus; the study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Apidra (insulin glulisine)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus | Phase 1 | Status: COMPLETED